Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|February 26, 2010
Breast cancer molecular profiling with single sample predictors: a retrospective analysisBritta Weigelt, Alan Mackay, Roger A'hern, et al.
Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Cancer Research|April 8, 2014
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistanceCharlotte K Y Ng, Britta Weigelt, Roger A'Hern, et al.
Journal of Carcinogenesis|March 26, 2005
Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase M1/T1 null genotypeSameer G Jhavar, Rajiv Sarin, Supriya Chopra, et al.
Journal of the National Cancer Institute|January 18, 2007
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancerMitch Dowsett, Ian E Smith, Stephen R Ebbs, et al.
Breast Cancer Research and Treatment|August 11, 2010
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancerLesley-Ann Martin, Giles L S Davies, Marion T Weigel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2005
The impact of introducing intensity modulated radiotherapy into routine clinical practiceElizabeth A Miles, Catharine H Clark, M Teresa Guerrero Urbano, et al.
Haematologica|March 17, 2004
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytesIlaria Del Giudice, Estella Matutes, Ricardo Morilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistanceAnita K Dunbier, Zara Ghazoui, Helen Anderson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2003
Le Fort I osteotomy and low-dose rate Ir192 brachytherapy for treatment of recurrent nasopharyngeal tumoursCharles E J Hall, Robert Harris, Roger A'Hern, et al.
Pageof 8